MEDP

Medpace Holdings, Inc. NMS · MEDP

$537.73 -0.19 (-0.04%)

Neutral · +0.96σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $15.4B

P/E (ttm) 33.8

Forward P/E 28.7

Beta (5y) 1.15

Shares out 28.6M

Div yield —

Profitability & returns

ROE 77.3%

Net margin 17.2%

FCF margin 18.3%

Debt / equity 0.24

Trading information

Last price $537.73

Day range $527.00 – $540.86

52-wk range $373.00 – $624.00

Avg volume 0.4M

RSI (2) 66.8

Trend zone Neutral

52-week range · today's price

$373.00$624.00

Company

Sector Healthcare

Industry Diagnostics & Research

Exchange NMS

Next earnings 2026-07-22

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; …